The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine Article

Good, Misty, Sodhi, Chhinder P, Yamaguchi, Yukihiro et al. (2016). The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine . BRITISH JOURNAL OF NUTRITION, 116(7), 1175-1187. 10.1017/S0007114516002944

Open Access

cited authors

  • Good, Misty; Sodhi, Chhinder P; Yamaguchi, Yukihiro; Jia, Hongpeng; Lu, Peng; Fulton, William B; Martin, Laura Y; Prindle, Thomas; Nino, Diego F; Zhou, Qinjie; Ma, Congrong; Ozolek, John A; Buck, Rachael H; Goehring, Karen C; Hackam, David J

sustainable development goals

authors

publication date

  • October 1, 2016

published in

keywords

  • 2 '-Fucosyllactose
  • BINDING
  • BIRTH-WEIGHT INFANTS
  • BREAST-MILK
  • Breast milk
  • Endothelial nitric oxide synthase
  • GLYCANS
  • GROWTH-FACTOR
  • Human milk oligosaccharides
  • INNATE IMMUNE-SYSTEM
  • Life Sciences & Biomedicine
  • MICROBIOTA
  • Necrotising enterocolitis
  • Nutrition & Dietetics
  • RAT
  • Science & Technology
  • TLR4
  • TOLL-LIKE RECEPTOR

Digital Object Identifier (DOI)

publisher

  • CAMBRIDGE UNIV PRESS

start page

  • 1175

end page

  • 1187

volume

  • 116

issue

  • 7